Stocks TelegraphStocks Telegraph
Stock Ideas

Ronald Kamdem

Morgan Stanley | Real Estate

Ronald Kamdem is an analyst from Morgan Stanley specializing in the Real Estate sector. Ranked #1779 out of 4769 analysts, they have issued 53 stock ratings with a success rate of 91.93% and an average return of 8.89%.

Ronald Kamdem has a well-established track record, with 53 ratings issued in the Real Estate sector. They have consistently delivered a success rate of 91.93% and an average return of 8.89%, underscoring their expertise and ability to identify winning opportunities for investors.

#1779
Out of 4769
53
Total Ratings
+91.93%
Success Rate
+8.89%
Average Return

Recent Ratings Analysis

LINE

Buy

Sep 09, 2026

Target

$47.00

Current

$37.59

Performance

0.00%

Ronald Kamdem rated LINE as Overweight on Sep 09, 2026, setting a price target of 47. Shares have remained stable near 37.59, leaving the 47 target still in play.

WELL

Buy

Sep 01, 2026

Target

$251.00

Current

$235.97

Performance

-1.85%

On Sep 01, 2026, WELL was given a Overweight rating by Ronald Kamdem, with a target price of 251. The stock traded sideways with a -1.85% move, keeping the bullish thesis unresolved.

SNDA

Hold

Sep 01, 2026

Target

$44.00

Current

$39.57

Performance

4.68%

SNDA received a Equal-Weight rating from Ronald Kamdem on Sep 01, 2026, aiming for 44. Shares remained flat at 39.57, aligning with the neutral rating.

JAN

Buy

Aug 18, 2026

Target

$31.00

Current

$31.00

Performance

1.94%

On Aug 18, 2026, Ronald Kamdem published a Overweight outlook on JAN, with a target of 31. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 31.

VNO

Sell

Jul 22, 2026

Target

$32.00

Current

$34.68

Performance

-9.95%

Ronald Kamdem on Jul 22, 2026 assigned VNO a Underweight rating, with a price target of 32. Market strength contradicted the bearish call as shares gained -9.95%.

HPP

Sell

Jul 22, 2026

Target

$9.00

Current

$11.91

Performance

-17.52%

On Jul 22, 2026, Ronald Kamdem reaffirmed HPP with a Underweight rating, targeting 9. The outlook was invalidated by a rebound to 11.91.

HIW

Hold

Jul 22, 2026

Target

$35.00

Current

$30.28

Performance

-6.83%

HIW was rated Equal-Weight by Ronald Kamdem on Jul 22, 2026, with a price objective of 35. Investors who stayed cautious avoided some of the 6.83% decline.

NNN

Hold

Jul 20, 2026

Target

$50.00

Current

$44.13

Performance

-9.79%

On Jul 20, 2026, Ronald Kamdem initiated coverage on NNN with a Equal-Weight rating and target of 50. The rating matched the stock’s inability to hold above 44.13.

FVR

Hold

Jul 08, 2026

Target

$21.00

Current

$18.65

Performance

-9.64%

Ronald Kamdem issued a Equal-Weight recommendation for FVR on Jul 08, 2026, price target set at 21. Market action validated the conservative Hold outlook with shares at 18.65.

VICI

Hold

Jul 08, 2026

Target

$31.00

Current

$25.23

Performance

-3.30%

On Jul 08, 2026, VICI was evaluated by Ronald Kamdem, who gave a Equal-Weight rating and target of 31. Hold sentiment was validated by subdued trading with no breakout beyond 25.23.

GLPI

Hold

Jul 07, 2026

Target

$55.00

Current

$41.50

Performance

-5.83%

Ronald Kamdem rated GLPI as Equal-Weight on Jul 07, 2026, setting a price target of 55. The cautious Hold call aligned with subsequent weakness, as shares slipped 5.83%.

MAC

Hold

Jun 18, 2026

Target

$25.00

Current

$23.03

Performance

-2.54%

On Jun 18, 2026, MAC was given a Equal-Weight rating by Ronald Kamdem, with a target price of 25. Market indecision, reflected in sideways trading near 23.03, supported the cautious call.

CURB

Hold

Jun 18, 2026

Target

$30.00

Current

$29.31

Performance

-1.84%

CURB received a Equal-Weight rating from Ronald Kamdem on Jun 18, 2026, aiming for 30. Shares remained flat at 29.31, aligning with the neutral rating.

ARE

Sell

Jun 11, 2026

Target

$53.00

Current

$50.34

Performance

-4.60%

On Jun 11, 2026, Ronald Kamdem published a Underweight outlook on ARE, with a target of 53. The rating remains inconclusive as the market consolidates near 50.34.

SPG

Hold

Jun 10, 2026

Target

$207.00

Current

$204.53

Performance

-3.90%

Ronald Kamdem on Jun 10, 2026 assigned SPG a Equal-Weight rating, with a price target of 207. The Hold stance reflected consolidation, as shares held near 204.53.

PLD

Hold

May 27, 2026

Target

$151.00

Current

$135.66

Performance

-7.42%

On May 27, 2026, Ronald Kamdem reaffirmed PLD with a Equal-Weight rating, targeting 151. The Hold stance reflected market caution that was later justified.

NHP

Hold

May 18, 2026

Target

$16.00

Current

$16.25

Performance

8.05%

NHP was rated Equal-Weight by Ronald Kamdem on May 18, 2026, with a price objective of 16. Despite caution, upside momentum rewarded risk-takers with gains to 16.25.

REG

Buy

Apr 21, 2026

Target

$88.00

Current

$75.34

Performance

-5.84%

On Apr 21, 2026, Ronald Kamdem initiated coverage on REG with a Overweight rating and target of 88. The Buy call has yet to be validated as shares remain 12.66 away from the target.

SAFE

Sell

Jan 23, 2026

Target

$14.00

Current

$14.62

Performance

3.54%

Ronald Kamdem issued a Underweight recommendation for SAFE on Jan 23, 2026, price target set at 14. Investors remain in wait-and-see mode as shares stayed flat.

UE

Hold

Jan 06, 2026

Target

$22.00

Current

$20.83

Performance

9.40%

On Jan 06, 2026, UE was evaluated by Ronald Kamdem, who gave a Equal-Weight rating and target of 22. Investors who stayed in despite the Hold saw upside of 9.40%.

BNL

Hold

Dec 29, 2025

Target

$19.00

Current

$20.71

Performance

18.41%

Ronald Kamdem rated BNL as Equal-Weight on Dec 29, 2025, setting a price target of 19. Despite the Hold call, shares climbed 18.41% to 20.71, revealing unexpected momentum.

O

Hold

Dec 24, 2025

Target

$65.00

Current

$60.11

Performance

6.07%

On Dec 24, 2025, O was given a Equal-Weight rating by Ronald Kamdem, with a target price of 65. The stock rallied from 60.11 to 60.11 after the Hold rating, surprising to the upside.

NSA

Hold

Dec 05, 2025

Target

$32.00

Current

$43.40

Performance

46.47%

NSA received a Equal-Weight rating from Ronald Kamdem on Dec 05, 2025, aiming for 32. Investors saw gains of 46.47% that the cautious stance didn’t fully capture.

PSA

Hold

Dec 05, 2025

Target

$290.00

Current

$294.60

Performance

8.28%

On Dec 05, 2025, Ronald Kamdem published a Equal-Weight outlook on PSA, with a target of 290. The Hold call missed some of the bullish momentum as shares advanced toward 290.

EXR

Hold

Dec 05, 2025

Target

$155.00

Current

$135.63

Performance

4.69%

Ronald Kamdem on Dec 05, 2025 assigned EXR a Equal-Weight rating, with a price target of 155. The Hold stance reflected consolidation, as shares held near 135.63.

AHR

Buy

Nov 20, 2025

Target

$55.00

Current

$53.77

Performance

9.22%

On Nov 20, 2025, Ronald Kamdem reaffirmed AHR with a Overweight rating, targeting 55. The recommendation was supported by strong follow-through as the stock rose from 53.77 to 53.77.

PGRE

Hold

Oct 22, 2025

Target

$6.60

Current

$6.60

Performance

1.23%

PGRE was rated Equal-Weight by Ronald Kamdem on Oct 22, 2025, with a price objective of 6.6. Flat performance suggests the Hold view was reasonable.

CBRE

Buy

Oct 07, 2025

Target

$180.00

Current

$139.78

Performance

-8.46%

On Oct 07, 2025, Ronald Kamdem initiated coverage on CBRE with a Overweight rating and target of 180. The Buy call has yet to be validated as shares remain 40.22 away from the target.

Frequency Asked Questions

Who is Ronald Kamdem?
Ronald Kamdem is an analyst from Morgan Stanley specializing in the Real Estate sector.
What is Ronald Kamdem's success rate?
Ronald Kamdem currently has a success rate of +91.93%.
How many ratings has Ronald Kamdem issued?
Ronald Kamdem has issued 53 stock ratings so far.
What is the average return of Ronald Kamdem's calls?
Their stock ratings have generated an average return of +8.89%.
What is Ronald Kamdem's ranking?
Ronald Kamdem is ranked #1779 out of 4769 analysts.
What types of ratings does Ronald Kamdem give?
Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.
How can I follow Ronald Kamdem?
You can follow Ronald Kamdem by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.
What is the most recent rating by Ronald Kamdem?
Their latest rating was a Buy on LINE issued on 2026-09-09.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph